At the hearing, Dr. David Kimberlin, who specializes in pediatric infectious disease at the University of Alabama at Birmingham, spoke of a situation in September, around the time Daraprim's
price went up after Turing bought the rights to the
drug, in which he found barriers to getting the
drug because the
monthly cost for four tablets suddenly spiked to $ 3,000 from $ 54.
The discounted
pricing also applies to PreCheck's license management outsourcing solution for human resources,
drug screen screening solutions, exclusion screening services for annual and / or
monthly screens, E-Verify solution, as well as an employment verifications outsourcing solution.